LambdaVision is developing a protein-based retinal implant to restore vision to the tens of millions blinded by age-related macular degeneration and retinitis pigmentosa. There is no cure for these diseases and current treatments only slow their progression, and people are going blind. LambdaVision's flexible, minimally-invasive, subretinal design, is the first to use a photoactive protein to replace the function of the damaged photoreceptor cells to provide high-resolution vision.

2016 Boston Sidecar Winner
Sub industry